Books by Rajeev Chawla

Provides detailed information on the novel drug class SGLT-2 inhibitors for the treatment of diabetes. All current evidences, studies and available data have been incorporated. An in depth search of literature on all topics traces how SGLT-2 inhibitors have evolved and are now a preferred option in management of type 2 diabetes.